Bio Pharma
The science, scale-up and economics reshaping biologics and advanced therapies.
Farmaci biologiciTerapie cellulari e genicheCMCScale-up
ArticoloStoria di apertura
Every Company Announced Fill-Finish Capacity: Still Scarce?
Everyone announced more fill-finish capacity, so why is it still one of biopharma's tightest bottlenecks? Here's the gap between announcement and reality.
Simantini Singh Deo · 28 ago 2026
Articolo
Why Oral GLP-1 Manufacturing Capacity Decides The Leader
Behind every oral GLP-1 approval is a manufacturing story, here's why factory capacity, not trial data, could decide who leads this market.
Simantini Singh Deo · 26 ago 2026